FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

DOS - 76050 - The President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board - Agency Authority

GENERAL INFORMATION

Committee Name	The President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board	Agency Name	Department of State
Fiscal Year	2025	Committee Number	76050
Original Establishment Date	11/5/2010	Committee Status	Chartered
Actual Termination Date		Committee URL	https://www.state.gov/scientific-advisory-board...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	Unlimited
Terminated This FY	No	Designated Fed Officer Position Title*	DFO
Merged This FY		Designated Federal Officer Prefix	Dr.
Current Charter Date	2/25/2025	Designated Federal Officer First Name*	Emily
Date Of Renewal Charter	2/25/2027	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Innis
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority	Public Law 92-463, Section 14	Designated Federal Officer Phone*	202 372-7867
Establishment Authority*	Agency Authority	Designated Federal Officer Fax*
Specific Establishment Authority*	Secretary of State and Department of State (Section 2656 of Title 22 of the United States Code)	Designated Federal Officer Email*	innisea@state.gov
Effective Date Of Authority*	12/5/2010
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Other Committee

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Board serves the U.S. Global AIDS Coordinator (“the Coordinator”) in a solely advisory capacity concerning scientific, implementation, and policy issues related to the global response to HIV/AIDS. These issues will be of concern as they influence the priorities and direction of PEPFAR evaluation and research, the content of national and international strategies and implementation, and the role of PEPFAR in the international discourse regarding appropriate and resourced responses. The committee accomplishes is purpose largely through the generation of recommendations.
How is membership balanced?*	The Board is composed of up to 50 members appointed by the Coordinator, representing non-U.S. Government personnel. All Board members are representative members. The membership is representative of the HIV/AIDS community, academia, international experts, partner government representatives, multilateral and bilateral agency representatives, foundations, advocates, and non-governmental organizations.
How frequent & relevant are cmte mtgs?*	Original Estimated Number of Meetings per Year - 1 or 2 face-to-face meetings with teleconferences as needed. In order to keep committee meetings relevant and productive, working groups (subcommittees) have been formed that meet intermittently and on an ad-hoc basis. The ideas and advice generated by the working groups result in increased productivity and clearer recommendations produced by the whole committee during face-to-face meetings.
Why advice can't be obtained elsewhere?*	The committee is necessary to keep PEPFAR programs at the forefront of scientific knowledge. The members of the committee have specific expertise which is relevant and crucial to PEPFAR in creating and implementing high-quality programs. The advice received by the Coordinator from the committee in the past fiscal year has assisted PEPFAR by informing next steps on how to swiftly pivot programs to achieve greater impact in response to new HIV normative guidance from the World Health Organization and others.
Why close or partially close meetings?	N/A
Recommendation Remarks	This committee advises PEPFAR on science, implementation, and technical policy issues. Its function is best described as "Other" due to this broad scope. Further, this committee does not routinely produce formal reports, but does issue recommendations on policy decisions that are captured in the meeting minutes following each meeting. For a full meeting summary, including recommendations offered by the Board, please follow the link below where you may find past meeting minutes. Please see www.state.gov/scientific-advisory-board-pepfar/ It was determined during this fiscal year that the majority of the SAB members would be retired to bring in new perspectives and reform the SAB. 5 members of the SAB were retained and the rest were informed of the retirement on September 24 2024. New members will be onboarding in the coming fiscal year and are currently being contacted. The following subcommittees were retired as they were inactive in 2023 and 2024: (1) Finance and Economics Working Group; (2) HIV Prevention Continuum Working Group; and (3) HIV Recency Testing.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	N/A
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	N/A	Number Of Grants Recommended	0
Cost Savings*	Cost Savings Other	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	This is not the purpose of the committee and is difficult to quantify. However, recommendations have directly contributed to programmatic efficiencies that in turn extend the value of the PEPFAR dollar.	Grants Review Comment	N/A
Number Of Recommendations*	60	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Through the FY22 reporting period, the PEPFAR Scientific Advisory Board has issued 65 recommendations. FY22 recommendations focused on the technical considerations for the implementation of HIV recency testing for surveillance, new biomedical products for HIV prevention, implementation science, use of self-testing for PrEP, and HPV testing. Through the FY23 reporting period, the PEPFAR Scientific Advisory Board convened to discuss the role of the Board during the formation of the GHSD bureau, and to discuss updates in science related to PEPFAR programs. During the FY 2024 period, the five recommendations provided by the board covered issues such as inclusive HIV care for key populations, addressing stagnant funding and equity, monitoring Dolutegravir resistance, advancing long-acting treatments, behavioral science for improved outcomes, and sustainable health system integration.	Access Agency Website	Yes
% of Recs Fully Implemented*	85.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	To date, approximately 85% of all recommendations have been fully implemented by the agency, and progress is being made to partially and fully implement additional recommendations.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	14.00%	Access Publications	No
% of Recs Partially Implemented Comment	Based on the broad nature of many of the recommendations issued by the Board through the FY24 reporting period, roughly 14% of recommendations are most accurately described as partially implemented.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	PEPFAR provides feedback at : https://www.state.gov/scientific-advisory-board-pepfar/	Narrative Description*	The Board serves the Global AIDS Coordinator (“the Coordinator”) in a solely advisory capacity concerning scientific, implementation, and policy issues related to the global response to HIV/AIDS. These issues are of ongoing concern and serve to maximize the impact of our investments in controlling the HIV epidemic and delivering on the promise of an AIDS-free generation.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/12/2025 10:07 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Public Health Medicine Diseases Health and Health Research

Custom Links

Committee Level Reports